Australia markets close in 5 hours 47 minutes

bluebird bio, Inc. (BLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.1000+0.0800 (+7.84%)
At close: 04:00PM EST
1.1000 0.00 (0.00%)
After hours: 05:55PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.0200
Open1.0400
Bid1.1000 x 21500
Ask1.1100 x 29200
Day's range1.0200 - 1.1300
52-week range0.8800 - 5.6200
Volume7,153,310
Avg. volume12,948,220
Market cap212.016M
Beta (5Y monthly)0.72
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    bluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024 Financial Outlook

    SOMERVILLE, Mass., January 08, 2024--bluebird bio, Inc. (Nasdaq: BLUE) (the Company; bluebird) today announced updates to be presented at the 42nd Annual J.P. Morgan Healthcare conference including commercial launch progress, 2024 program milestones and financial outlook. Andrew Obenshain, chief executive officer, is scheduled to present Tuesday, January 9 at 10:30 a.m. PT/1:30 p.m. ET.

  • Business Wire

    bluebird bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

    SOMERVILLE, Mass., January 02, 2024--bluebird bio, Inc. (Nasdaq: BLUE) today announced that Andrew Obenshain, chief executive officer, bluebird bio, will present a corporate update at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 10:30am PT/1:30pm ET.

  • Business Wire

    bluebird bio, Inc. Announces Pricing of $125 Million Public Offering of Common Stock

    SOMERVILLE, Mass., December 20, 2023--bluebird bio, Inc. (Nasdaq: BLUE) ("bluebird") today announced the pricing of its underwritten public offering of 83,333,333 shares of its common stock at a public offering price of $1.50 per share, before deducting underwriting discounts and commissions. bluebird also granted the underwriters a 30-day option to purchase up to an additional 12,499,999 shares of its common stock at the public offering price per share, less underwriting discounts and commissio